PAUL C GRINT
CIK 1236548 · Chief Executive Officer · last filed 2024-07-18
PAUL C GRINT is a Chief Executive Officer who has filed 29 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for IKT, was dated Jul 18, 2024. Across all open-market trades the lifetime net is −$1.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.35M
4
29
-$1.46M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IKT | Director | — | $1.67 | — | $0 | 5 | 2024-07-18 |
| Armata Pharmaceuticals, Inc. (APHB) Delisted | Chief Executive Officer | 599 | — | — | $0 | 3 | 2017-12-12 |
| Regulus Therapeutics Inc. (RGLS) Delisted | President & CEO | — | $8.16 | — | $0 | 8 | 2017-02-23 |
| ILMN | Director | 8,365 | $160.97 | $1.35M | -$1.46M | 13 | 2013-01-07 |
Recent Filings
29 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-07-18 | IKT | Grant (A) | — | $0 | EDGAR |
| 2023-07-05 | IKT | Grant (A) | — | $0 | EDGAR |
| 2022-06-28 | IKT | Grant (A) | — | $0 | EDGAR |
| 2021-06-29 | IKT | Grant (A) | — | $0 | EDGAR |
| 2020-12-29 | IKT | Grant (A) | — | $0 | EDGAR |
| 2017-12-12 | Armata Pharmaceuticals, Inc. (APHB) Delisted | Grant (A) | +599 | $371 | EDGAR |
| 2017-09-11 | Armata Pharmaceuticals, Inc. (APHB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-02-23 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-02-01 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-10-07 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | — | $0 | EDGAR |